L-Carnitine as a treatment of life-threatening lactic acidosis induced by nucleoside analogues.
Claessens
Y E
YE
Cariou
A
A
Chiche
J D
JD
Dauriat
G
G
Dhainaut
J F
JF
D000140:Acidosis, Lactic / Q000139:chemically induced / Q000188:drug therapy*; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002331:Carnitine / Q000627:therapeutic use*; D016049:Didanosine / Q000008:administration & dosage / Q000009:adverse effects; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage; D006801:Humans; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D019258:Saquinavir / Q000008:administration & dosage; D018119:Stavudine / Q000008:administration & dosage / Q000009:adverse effects
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D018119:Stavudine; D016049:Didanosine; D019258:Saquinavir; D002331:Carnitine